Jeff Evanson Outlook Therapeutics, Inc. (OTLK) insider trading activity

Jeff Evanson is CHIEF COMMERCIAL OFFICER of Outlook Therapeutics, Inc.. Currently has a direct ownership of 808,459 shares of OTLK, which is worth approximately $4.5 Million. The most recent transaction as insider was on Mar 07, 2024, when has been sold 62,484 shares (Common Stock) at a price of $0.42 per share, resulting in proceeds of $26,243. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 808K

0% 3M change

8.38% 12M change

Total Value Held $4.5 Million

Jeff Evanson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2024	BUY Open market or private purchase	$26,243 $0.42 p/Share	62,484 Added 7.17%	808,459 Common Stock
Jan 20 2023	SELL Open market or private sale	$296,370 $1.11 p/Share	267,000 Reduced 26.36%	745,975 Common Stock
Jan 19 2023	SELL Open market or private sale	$125,971 $1.22 p/Share	103,255 Reduced 9.25%	1,012,975 Common Stock
Jan 18 2023	SELL Open market or private sale	$42,172 $1.25 p/Share	33,738 Reduced 2.93%	1,116,230 Common Stock
Jan 17 2023	SELL Open market or private sale	$35,582 $1.31 p/Share	27,162 Reduced 2.31%	1,149,968 Common Stock
Dec 03 2021	BUY Open market or private purchase	$47,168 $1.34 p/Share	35,200 Added 2.9%	1,177,130 Common Stock
Feb 23 2021	SELL Open market or private sale	$17,878 $2.09 p/Share	8,554 Reduced 0.74%	1,141,930 Common Stock
Feb 12 2021	SELL Open market or private sale	$145,281 $2.55 p/Share	56,973 Reduced 4.72%	1,150,484 Common Stock

Jeff Evanson

CHIEF COMMERCIAL OFFICER

Monmouth Junction, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Value

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Outlook Therapeutics, Inc.

Track Activities on OTLK

Account